5/23/2022 8:05:33 AM
Teva : Analysis Finds AUSTEDO Provided Improvements In TD-related Movements In Postmenopausal Women
5/17/2022 9:13:55 AM
United Kingdom Grants License For Teva's Ophthalmology Biosimilar
Ongavia
5/17/2022 7:50:41 AM
Teva Says New Findings Shows Potential Of ProAir Digihaler
Inhalation Powder To Address Asthma Treatment Challenges
5/3/2022 7:16:21 AM
Teva Pharmaceutical Industries Limited (TEVA) Has Lowered Its FY22 Revenue Estimate To $15.4 - $16.0 Bln From $15.6 - $16.2 Bln
5/3/2022 7:03:26 AM
Teva Pharma Q1 GAAP Loss Per Share $0.86; Non-GAAP EPS $0.55
5/2/2022 8:04:28 AM
Teva Reaches Settlement With Lupin Resolving AUSTEDO
Patent Dispute
4/5/2022 7:36:38 AM
Teva Canada Launches Series Of Five Podcasts; New Initiatives Planned To Spark Dialogue On Future Healthcare Delivery
3/30/2022 9:15:41 AM
Teva Reaches Deal With Florida To Settle State's Opioid-Related Claims
3/21/2022 3:13:21 PM
Teva Reaches Agreement With Rhode Island To Settle Opioid-Related Claims